Brian Lord

3.4k total citations
65 papers, 2.6k citations indexed

About

Brian Lord is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Brian Lord has authored 65 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 21 papers in Cellular and Molecular Neuroscience and 16 papers in Physiology. Recurrent topics in Brian Lord's work include Receptor Mechanisms and Signaling (18 papers), Mast cells and histamine (16 papers) and Adenosine and Purinergic Signaling (15 papers). Brian Lord is often cited by papers focused on Receptor Mechanisms and Signaling (18 papers), Mast cells and histamine (16 papers) and Adenosine and Purinergic Signaling (15 papers). Brian Lord collaborates with scholars based in United States, Belgium and Netherlands. Brian Lord's co-authors include Timothy W. Lovenberg, Pascal Bonaventure, Nicholas I. Carruthers, Leah Aluisio, Michael A. Letavic, Christine Dugovic, Ian Fraser, Anindya Bhattacharya, Jamin D. Boggs and Curt Mazur and has published in prestigious journals such as Neuron, PLoS ONE and Biological Psychiatry.

In The Last Decade

Brian Lord

64 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brian Lord United States	31	949	612	540	536	514	65	2.6k
Leah Aluisio United States	24	473 0.5×	391 0.6×	533 1.0×	264 0.5×	568 1.1×	32	1.7k
Maria Beatrice Passani Italy	37	1.7k 1.8×	977 1.6×	656 1.2×	221 0.4×	601 1.2×	101	3.8k
Estefanía Moreno Spain	36	1.9k 2.0×	1.9k 3.1×	270 0.5×	433 0.8×	355 0.7×	76	3.6k
Malika El Yacoubi France	24	1.3k 1.3×	1.5k 2.5×	237 0.4×	1.1k 2.0×	285 0.6×	41	3.3k
Zuzana Justinová United States	38	1.2k 1.2×	2.4k 4.0×	225 0.4×	291 0.5×	458 0.9×	65	3.7k
Xavier Langlois Belgium	38	2.1k 2.2×	2.3k 3.8×	184 0.3×	141 0.3×	397 0.8×	104	4.2k
J. Schwartz France	30	2.0k 2.1×	2.1k 3.4×	487 0.9×	43 0.1×	355 0.7×	81	3.8k
Soumen Paul United States	24	983 1.0×	1.6k 2.5×	114 0.2×	192 0.4×	321 0.6×	48	2.7k
Tolga Uz United States	32	669 0.7×	834 1.4×	1.2k 2.2×	28 0.1×	611 1.2×	65	2.8k
Valérie Audinot France	37	2.1k 2.2×	2.5k 4.0×	1.0k 1.9×	36 0.1×	382 0.7×	98	4.7k

Countries citing papers authored by Brian Lord

Since Specialization

Citations

This map shows the geographic impact of Brian Lord's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Lord with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Lord more than expected).

Fields of papers citing papers by Brian Lord

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Lord. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Lord. The network helps show where Brian Lord may publish in the future.

Co-authorship network of co-authors of Brian Lord

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Lord. A scholar is included among the top collaborators of Brian Lord based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Lord. Brian Lord is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lord, Brian, Anindya Bhattacharya, Jason C. Rech, et al.. (2024). Characterization of tritiated JNJ‐GluN2B‐5 (3‐[ ³ H] 1‐(azetidin‐1‐yl)‐2‐(6‐(4‐fluoro‐3‐methyl‐phenyl)pyrrolo[3,2‐ b ]pyridin‐1‐yl)ethanone), a high affinity GluN2B radioligand with selectivity over sigma receptors. Journal of Neurochemistry. 168(9). 2654–2670. 1 indexed citations

McCarver, Stefan J., Luke Elizabeth Hanna, Aaron A. Thompson, et al.. (2024). Structure-Based Optimization of Selective and Brain Penetrant CK1δ Inhibitors for the Treatment of Circadian Disruptions. ACS Medicinal Chemistry Letters. 15(4). 486–492. 1 indexed citations

Gelin, Christine F., Heather Coate, Brian Lord, et al.. (2023). Discovery of a Series of Substituted 1H-((1,2,3-Triazol-4-yl)methoxy)pyrimidines as Brain Penetrants and Potent GluN2B-Selective Negative Allosteric Modulators. Journal of Medicinal Chemistry. 66(4). 2877–2892. 3 indexed citations

Dvorak, Curt A., Diane Nepomuceno, Lisa Dvorak, et al.. (2020). Discovery and SAR studies of 2-alkyl-3-phenyl-2,4,5,6,7,8-hexahydropyrazolo[3,4-d]azepines as 5-HT7/2 inhibitors leading to the identification of a clinical candidate. Bioorganic & Medicinal Chemistry Letters. 31. 127669–127669. 3 indexed citations

Salvadore, Giacomo, Pascal Bonaventure, Anantha Shekhar, et al.. (2020). Translational evaluation of novel selective orexin-1 receptor antagonist JNJ-61393215 in an experimental model for panic in rodents and humans. Translational Psychiatry. 10(1). 308–308. 31 indexed citations

Shoblock, James R., Natalie Welty, Ian Fraser, et al.. (2019). In vivo Characterization of a Selective, Orally Available, and Brain Penetrant Small Molecule GPR139 Agonist. Frontiers in Pharmacology. 10. 273–273. 13 indexed citations

Bonaventure, Pascal, Christine Dugovic, Brock T. Shireman, et al.. (2017). Evaluation of JNJ-54717793 a Novel Brain Penetrant Selective Orexin 1 Receptor Antagonist in Two Rat Models of Panic Attack Provocation. Frontiers in Pharmacology. 8. 357–357. 35 indexed citations

Amhaoul, Halima, Idrish Ali, Krystyna Szewczyk, et al.. (2016). P2X7 receptor antagonism reduces the severity of spontaneous seizures in a chronic model of temporal lobe epilepsy. Neuropharmacology. 105. 175–185. 54 indexed citations

Gu, Shenyan, José A. Matta, Brian Lord, et al.. (2016). Brain α7 Nicotinic Acetylcholine Receptor Assembly Requires NACHO. Neuron. 89(5). 948–955. 131 indexed citations

10.

Alcázar, Jesús, Michael K. Ameriks, Hong Ao, et al.. (2015). Novel methyl substituted 1-(5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)methanones are P2X7 antagonists. Bioorganic & Medicinal Chemistry Letters. 25(16). 3157–3163. 30 indexed citations

11.

Lord, Brian, Michael K. Ameriks, Qi Wang, et al.. (2015). A novel radioligand for the ATP-gated ion channel P2X7: [3H] JNJ-54232334. European Journal of Pharmacology. 765. 551–559. 45 indexed citations

12.

Bonaventure, Pascal, Jonathan Shelton, Sujin Yun, et al.. (2015). Characterization of JNJ-42847922, a Selective Orexin-2 Receptor Antagonist, as a Clinical Candidate for the Treatment of Insomnia. Journal of Pharmacology and Experimental Therapeutics. 354(3). 471–482. 71 indexed citations

13.

Lord, Brian, Leah Aluisio, James R. Shoblock, et al.. (2014). Pharmacology of a Novel Central Nervous System–Penetrant P2X7 Antagonist JNJ-42253432. Journal of Pharmacology and Experimental Therapeutics. 351(3). 628–641. 65 indexed citations

14.

Bonaventure, Pascal, Leah Aluisio, James R. Shoblock, et al.. (2011). Pharmacological Blockade of Serotonin 5-HT7 Receptor Reverses Working Memory Deficits in Rats by Normalizing Cortical Glutamate Neurotransmission. PLoS ONE. 6(6). e20210–e20210. 42 indexed citations

15.

Jablonowski, Jill A., Kiev S. Ly, Curt A. Dvorak, et al.. (2008). Novel imidazole-based histamine H3 antagonists. Bioorganic & Medicinal Chemistry Letters. 19(3). 903–907. 7 indexed citations

16.

Letavic, Michael A., Emily M. Stocking, Ann Barbier, et al.. (2007). Benzylamine histamine H3 antagonists and serotonin reuptake inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(17). 4799–4803. 9 indexed citations

17.

Bonaventure, Pascal, Lisa A. Kelly, Leah Aluisio, et al.. (2007). Selective Blockade of 5-Hydroxytryptamine (5-HT)7 Receptors Enhances 5-HT Transmission, Antidepressant-Like Behavior, and Rapid Eye Movement Sleep Suppression Induced by Citalopram in Rodents. Journal of Pharmacology and Experimental Therapeutics. 321(2). 690–698. 139 indexed citations

18.

Ly, Kiev S., Michael A. Letavic, John M. Keith, et al.. (2007). Synthesis and biological activity of piperazine and diazepane amides that are histamine H3 antagonists and serotonin reuptake inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(1). 39–43. 19 indexed citations

19.

Keith, John M., Ann Barbier, Sandy J. Wilson, et al.. (2007). Pyrrolidino-tetrahydroisoquinolines bearing pendant heterocycles as potent dual H3 antagonist and serotonin transporter inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(15). 4374–4377. 25 indexed citations

20.

Keith, John M., Ronald Wolin, Ann Barbier, et al.. (2007). Pyrrolidino-tetrahydroisoquinolines as potent dual H3 antagonist and serotonin transporter inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(9). 2603–2607. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact